The Journal of Thoracic and Cardiovascular Surgery
Volume 127, Issue 2 , Pages 344-354 , February 2004

Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration

  • Andreas Günther, MD

      Affiliations

    • Department of Internal Medicine, Justus Liebig University, Giessen, Germany
    • Corresponding Author InformationAddress for reprints: Dr Andreas Günther, Department of Internal Medicine, Justus-Liebig-University Giessen, Klinikstrasse 36, D-35392 Giessen, Germany
    • ,
  • Markus Balser, MD

      Affiliations

    • Department of Internal Medicine, Justus Liebig University, Giessen, Germany
    • ,
  • Reinhold Schmidt, PhD

      Affiliations

    • Department of Internal Medicine, Justus Liebig University, Giessen, Germany
    • ,
  • Philipp Markart, MD

      Affiliations

    • Department of Internal Medicine, Justus Liebig University, Giessen, Germany
    • ,
  • Alexander Olk, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University, Halle, Germany
    • ,
  • Jochen Börgermann, MD

      Affiliations

    • Department Thoracic and Cardiovascular Surgery, University Essen, Essen, Germany
    • ,
  • Fred H Splittgerber, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University, Halle, Germany
    • ,
  • Werner Seeger, MD

      Affiliations

    • Department of Internal Medicine, Justus Liebig University, Giessen, Germany
    • ,
  • Ivar Friedrich, MD

      Affiliations

    • Department Thoracic and Cardiovascular Surgery, University Essen, Essen, Germany

Received 12 August 2002 ,Accepted 11 September 2003.

References 

  1. Hawgood S. Surfactant: composition, structure, and metabolism. In:  Crystal RG,  West JB editor. The lung: scientific foundations. New York: Raven Press; 1991;p. 247–261
  2. Bachofen H, Schürch S, Urbinelli M, Weibel ER. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol. 1987;62:1878–1887
  3. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;147:218–233
  4. Günther A, Siebert C, Schmidt R, et al.  Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996;153:176–184
  5. Walmrath D, Günther A, Ghofrani HA, et al.  Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med. 1996;154:57–62
  6. Gregory TJ, Steinberg KP, Spragg R, et al.  Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:1309–1315
  7. Walmrath D, Grimminger F, Pappert D, et al.  Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock (impact on gas exchange and haemodynamics). Eur Respir J. 2002;19:805–810
  8. Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation. 1994;58:1158–1162
  9. Novick RJ, Possmayer F, Veldhuizen RA, Menkis AH, McKenzie FN. Surfactant analysis and replacement therapy (a future tool of the lung transplant surgeon?). Ann Thorac Surg. 1991;52:1194–1200
  10. Ochs M, Nenadic I, Fehrenbach A, et al.  Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med. 1999;160:718–724
  11. Novick RJ, McDonald J, Veldhuizen RAW, et al.  Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med. 1996;154:98–104
  12. Casals C, Varela A, Ruano MLF, et al.  Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med. 1998;157:43–49
  13. Veldhuizen RA, Lee J, Sandler D, et al.  Alteration in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis. 1993;148:208–215
  14. Novick RJ, Gilpin AA, Gehman KE, et al.  Mitigation of injury in canine lung crafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg. 1997;113:342–353
  15. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins (differential sensitivity of various surfactant preparations). Eur Respir J. 1993;6:971–977
  16. Friedrich I, Börgermann J, Splittgerber FH, Brinkmann M, Reidemeister JC, Silber RE, et al.  Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. J Thorac Cardiovasc Surg. 2004;127:335–343
  17. Schmidt R, Meier U, Yabut-Perez M, et al.  Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome (ARDS) and severe pneumonia. Am J Respir Crit Care Med. 2001;163:95–100
  18. Eder K. Gas chromatographic analysis of fatty acid methyl esters. J Chromatogr Biomed Appl. 1995;671:113–131
  19. Ruestow B, Schlame M, Haupt R, Wilhelm D, Kunze D. Studies on the formation of dipalmitoyl species of phosphatidylcholine and phosphatidylethanolamine in pulmonary type II cells. Biochem J. 1992;282:453–458
  20. Krämer HJ, Schmidt R, Günther A, Becker G, Suzuki Y, Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1995;152:1540–1544
  21. Schmidt R, Steinhilber W, Ruppert C, et al.  An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 2002;165:470–474
  22. Warr RG, Hawgood S, Buckley DI, et al.  Low molecular weight human pulmonary surfactant protein (SP5) (isolation, characterization, and cDNA and amino acid sequences). Proc Natl Acad Sci U S A. 1987;84:7915–7919
  23. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol. 1977;43:198–203
  24. Gross NJ, Narine KR. Surfactant subtypes of mice (metabolic relationships and conversion in vitro). J Appl Physiol. 1989;67:414–421
  25. Günther A, Schmidt R, Feustel A, et al.  Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in the large surfactant aggregates—experimental and clinical studies. Am J Respir Crit Care Med. 1999;159:244–251
  26. Veldhuizen R, Inchley K, Hearn SA, Lewis JF, Possmayer F. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J. 1993;295:141–147
  27. Lewis JF, Ikegami M, Jobe AH. Metabolism of exogenously administered surfactant in the acutely injured lungs of adult rabbits. Am Rev Respir Dis. 1992;145:19–23
  28. Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang Oetomo S, Prop J. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med. 1996;153:665–670
  29. Hohlfeld JM, Struber M, Ahlf K, et al.  Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J. 1999;13:1037–1043
  30. Slutsky S. Lung injury caused by mechanical ventilation. Chest. 1999;116:9S–15S
  31. Hohlfeld JM, Tiryaki E, Hamm H, et al.  Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med. 1998;158:706–712
  32. Kahn MC, Anderson GJ, Anyan WR, Hall SB. Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol. 1995;269:L567–573
  33. Baritussio AG, Magoon MW, Goerke J, Clements JA. Precursor-product relationship between rabbit type II cell lamellar bodies and alveolar surface-active material. Surfactant turnover time. Biochim Biophys Acta. 1981;666:382–393
  34. Pettenazzo A, Jobe A, Humme J, Seidner S, Ikegami M. Clearance of surfactant phosphatidylcholine via the upper airways in rabbits. J Appl Physiol. 1988;65:2151–2155
  35. Venkitaraman AR, Hall SB, Whitsett JA, Notter RH. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipids. 1990;56:185–194

☆ This study was supported by the Deutsche Forschungsgemeinschaft (SFB 547).

PII: S0022-5223(03)01568-X

doi: 10.1016/j.jtcvs.2002.09.001

The Journal of Thoracic and Cardiovascular Surgery
Volume 127, Issue 2 , Pages 344-354 , February 2004

Article Tools

* Image Usage & Resolution